Emily Drinkward, PA-C

Emily Drinkward practices at Sathya Pratap Pokala MD Inc in La Mesa, California.

Emily Drinkward's NPI, 1770298267, was assigned on January 18, 2023.

Emily Drinkward's primary practice is Sathya Pratap Pokala MD Inc, at 8851 Center Dr, La Mesa, CA 91942 in San Diego County. The practice phone is (619) 644-9315.

Emily Drinkward's primary practice is Sathya Pratap Pokala MD Inc in La Mesa, California. Emily Drinkward is also affiliated with Sharp Grossmont Hospital. The medical group on file is Sharp Community Medical Group. Dmand AI also links Emily Drinkward to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Emily Drinkward practices, 4 sites in all. Vendor and product names are available with a free account.

Physician assistant is Emily Drinkward's primary specialty in the NPI Registry, under taxonomy code 363A00000X.

CMS data shows 25 Medicare services from Emily Drinkward across 1 procedure code in 2024, all of them office visits, for 25 Medicare patients. Medicare paid $2,321 for them. Every service was in an office.

CMS counts 25 Medicare patients who saw Emily Drinkward in 2024. The largest group is 65 to 74, with 12 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Emily Drinkward's median patient age at 71, with 59% women.

In 2024, Emily Drinkward wrote 917 Medicare Part D claims for 253 patients. 53% of them were for generic drugs. CMS names the drug for 717 of them, across 23 drugs with 11 or more claims each, at $369,122 in total drug cost.

Emily Drinkward accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 160 general payments to Emily Drinkward from 17 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 97% of the total. Sanofi and Genzyme US Companies paid the most, $1,114.